Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
|
Expensive Performer
6285.0000
-1.00
(
-0.02
%)
NSE
Apr 22, 2026
09:30 AM
Volume:
21,110
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
10 Nov 2025
6285.00
-0.02%
Divi's Laboratories (DIVI IN) Q2FY26 Result Update Peptides...
Accumulate:
Divi's Laboratories Ltd.
by
Prabhudas Lilladhar
Target: 7050 | Upside : 12.2%
Target
Prabhudas Lilladhar
Geojit BNP Paribas upgraded Divi's Laboratories Ltd. to Hold with a price target of 6336.0 on 06 Apr, 2026.
More from Divi's Laboratories Ltd.
Recommended
Market opens lower, Persistent Systems' net profit rises 20% QoQ in Q4FY26
Trendlyne Marketwatch |
22 Apr 2026, 09:21AM
IPOs see momentum despite global volatility; five companies coming up
|
20 Apr 2026, 06:11PM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022